ACTINIUM PHARMACEUTICALS, INC. Weighted Average Number of Shares Outstanding, Basic and Diluted
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 20.57 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-25.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-25
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 22.09M shares, a 38.86% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 21.54M shares, a 39.57% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 20.23M shares, a 77.79% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 18.38M shares, a 216.87% increase year-over-year.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 20.57M shares, a 69.51% increase from fiscal 2020.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 12.13M shares, a 143.87% increase from fiscal 2019.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 4.98M shares, a 95.31% decline from fiscal 2018.
- ACTINIUM PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 106.04M shares, a 58.87% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | 22.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | 21.82M shares derived: average of 2 quarters · filed 2022-03-25 | 21.29M shares derived: average of 3 quarters · filed 2022-03-25 | 20.57M shares 10-K · filed 2022-03-25 | ||||
| 2021-09-30 | 21.54M shares 10-Q · filed 2021-11-12 | 20.89M shares derived: average of 2 quarters · filed 2021-11-12 | 20.06M shares 10-Q · filed 2021-11-12 | 19.01M shares derived: average of 4 quarters · filed 2022-03-25 | ||||
| 2021-06-30 | 20.23M shares 10-Q · filed 2021-07-30 | 19.31M shares 10-Q · filed 2021-07-30 | 18.17M shares derived: average of 3 quarters · filed 2022-03-25 | 17.49M shares derived: average of 4 quarters · filed 2022-03-25 | ||||
| 2021-03-31 | 18.38M shares 10-Q · filed 2021-05-14 | 17.14M shares derived: average of 2 quarters · filed 2022-03-25 | 16.57M shares derived: average of 3 quarters · filed 2022-03-25 | 15.27M shares derived: average of 4 quarters · filed 2022-03-25 | ||||
| 2020-12-31 | 15.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | 15.67M shares derived: average of 2 quarters · filed 2022-03-25 | 14.24M shares derived: average of 3 quarters · filed 2022-03-25 | 12.13M shares 10-K · filed 2022-03-25 | ||||
| 2020-09-30 | 15.43M shares 10-Q · filed 2021-11-12 | 13.41M shares derived: average of 2 quarters · filed 2021-11-12 | 10.88M shares 10-Q · filed 2021-11-12 | 9.53M shares derived: average of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | 11.38M shares 10-Q · filed 2021-07-30 | 8.56M shares 10-Q · filed 2021-07-30 | 7.56M shares derived: average of 3 quarters · filed 2021-07-30 | 7.03M shares derived: average of 4 quarters · filed 2021-07-30 | ||||
| 2020-03-31 | 5.80M shares 10-Q · filed 2021-05-14 | 173.00M shares 10-Q · filed 2020-06-29 | 5.65M shares derived: average of 2 quarters · filed 2021-05-14 | 5.58M shares derived: average of 3 quarters · filed 2021-05-14 | 5.45M shares derived: average of 4 quarters · filed 2021-05-14 | |||
| 2019-12-31 | 5.50M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | 5.47M shares derived: average of 2 quarters · filed 2021-03-31 | 5.33M shares derived: average of 3 quarters · filed 2021-03-31 | 4.98M shares 10-K · filed 2021-03-31 | 149.27M shares 10-K · filed 2020-05-08 | |||
| 2019-09-30 | 5.44M shares 10-Q · filed 2020-10-23 | 163.34M shares 10-Q · filed 2019-11-12 | 5.25M shares derived: average of 2 quarters · filed 2020-10-23 | 4.80M shares 10-Q · filed 2020-10-23 | 144.07M shares 10-Q · filed 2019-11-12 | 60.59M shares derived: average of 4 quarters · filed 2020-10-23 | ||
| 2019-06-30 | 5.05M shares 10-Q · filed 2020-08-14 | 151.54M shares 10-Q · filed 2019-08-09 | 4.48M shares 10-Q · filed 2020-08-14 | 134.29M shares 10-Q · filed 2019-08-09 | 78.97M shares derived: average of 3 quarters · filed 2020-08-14 | 86.84M shares derived: average of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | 117.20M shares 10-Q · filed 2020-06-29 | 115.93M shares derived: average of 2 quarters · filed 2020-06-29 | 114.11M shares derived: average of 3 quarters · filed 2020-06-29 | 113.17M shares derived: average of 4 quarters · filed 2020-06-29 | ||||
| 2018-12-31 | 114.66M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-08 | 112.56M shares derived: average of 2 quarters · filed 2020-05-08 | 111.83M shares derived: average of 3 quarters · filed 2020-05-08 | 106.04M shares 10-K · filed 2020-05-08 | ||||
| 2018-09-30 | 110.46M shares 10-Q · filed 2019-11-12 | 110.41M shares derived: average of 2 quarters · filed 2019-11-12 | 103.17M shares 10-Q · filed 2019-11-12 | 97.36M shares derived: average of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | 110.36M shares 10-Q · filed 2019-08-09 | 99.46M shares 10-Q · filed 2019-08-09 | 92.99M shares derived: average of 3 quarters · filed 2019-08-09 | 87.88M shares derived: average of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | 88.43M shares 10-Q · filed 2019-05-10 | 84.31M shares derived: average of 2 quarters · filed 2019-05-10 | 80.39M shares derived: average of 3 quarters · filed 2019-05-10 | 74.84M shares derived: average of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | 80.18M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 76.36M shares derived: average of 2 quarters · filed 2019-03-15 | 70.30M shares derived: average of 3 quarters · filed 2019-03-15 | 66.75M shares 10-K · filed 2019-03-15 | ||||
| 2017-09-30 | 72.54M shares 10-Q · filed 2018-11-09 | 65.36M shares derived: average of 2 quarters · filed 2018-11-09 | 62.27M shares 10-Q · filed 2018-11-09 | 60.52M shares derived: average of 4 quarters · filed 2019-03-15 | ||||
| 2017-06-30 | 58.18M shares 10-Q · filed 2018-08-09 | 57.05M shares 10-Q · filed 2018-08-09 | 56.52M shares derived: average of 3 quarters · filed 2019-03-15 | 54.30M shares derived: average of 4 quarters · filed 2019-03-15 | ||||
| 2017-03-31 | 55.89M shares 10-Q · filed 2018-05-10 | 55.68M shares derived: average of 2 quarters · filed 2019-03-15 | 53.01M shares derived: average of 3 quarters · filed 2019-03-15 | 51.37M shares derived: average of 4 quarters · filed 2019-03-15 | ||||
| 2016-12-31 | 55.47M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 51.56M shares derived: average of 2 quarters · filed 2019-03-15 | 49.86M shares derived: average of 3 quarters · filed 2019-03-15 | 48.46M shares 10-K · filed 2019-03-15 | ||||
| 2016-09-30 | 47.65M shares 10-Q · filed 2017-11-03 | 47.06M shares derived: average of 2 quarters · filed 2017-11-03 | 46.13M shares 10-Q · filed 2017-11-03 | 44.95M shares derived: average of 4 quarters · filed 2018-03-16 | ||||
| 2016-06-30 | 46.47M shares 10-Q · filed 2017-08-04 | 45.36M shares 10-Q · filed 2017-08-04 | 44.05M shares derived: average of 3 quarters · filed 2018-03-16 | 43.33M shares derived: average of 4 quarters · filed 2018-03-16 | ||||
| 2016-03-31 | 44.25M shares 10-Q · filed 2017-05-15 | 42.84M shares derived: average of 2 quarters · filed 2018-03-16 | 42.28M shares derived: average of 3 quarters · filed 2018-03-16 | |||||
| 2015-12-31 | 41.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | 41.30M shares derived: average of 2 quarters · filed 2018-03-16 | 38.16M shares 10-K · filed 2018-03-16 | |||||
| 2015-09-30 | 41.17M shares 10-Q · filed 2015-10-30 | 37.07M shares 10-Q · filed 2015-10-30 | ||||||
| 2015-03-31 | 33.26M shares 10-Q · filed 2016-05-10 | 31.55M shares derived: average of 2 quarters · filed 2017-03-16 | 30.53M shares derived: average of 3 quarters · filed 2017-03-16 | |||||
| 2014-12-31 | 29.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 29.17M shares derived: average of 2 quarters · filed 2017-03-16 | 27.36M shares 10-K · filed 2017-03-16 | |||||
| 2014-09-30 | 28.50M shares 10-Q · filed 2015-10-30 | 26.54M shares 10-Q · filed 2015-10-30 | ||||||
| 2014-03-31 | 25.23M shares 10-Q · filed 2015-05-08 | 24.52M shares derived: average of 2 quarters · filed 2016-03-11 | 24.21M shares derived: average of 3 quarters · filed 2016-03-11 | 23.70M shares derived: average of 4 quarters · filed 2016-03-11 | ||||
| 2013-12-31 | 23.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | 23.70M shares derived: average of 2 quarters · filed 2016-03-11 | 23.20M shares derived: average of 3 quarters · filed 2016-03-11 | 22.75M shares 10-K · filed 2016-03-11 | ||||
| 2013-09-30 | 23.60M shares 10-Q · filed 2014-10-31 | 22.89M shares derived: average of 2 quarters · filed 2014-10-31 | 22.40M shares 10-Q · filed 2014-10-31 | 17.30M shares derived: average of 4 quarters · filed 2014-10-31 | ||||
| 2013-06-30 | 22.18M shares 10-Q · filed 2013-08-13 | 21.79M shares 10-Q · filed 2013-08-13 | 15.19M shares derived: average of 3 quarters · filed 2014-05-12 | 11.60M shares derived: average of 4 quarters · filed 2014-05-12 | ||||
| 2013-03-31 | 21.39M shares 10-Q · filed 2014-05-12 | 11.70M shares derived: average of 2 quarters · filed 2014-05-12 | 8.07M shares derived: average of 3 quarters · filed 2014-05-12 | 10.31M shares derived: average of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | 2.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | 1.41M shares derived: average of 2 quarters · filed 2014-02-28 | 6.61M shares derived: average of 3 quarters · filed 2014-02-28 | 1.10M shares 10-K · filed 2014-02-28 | ||||
| 2012-09-30 | 801.80K shares 10-Q · filed 2013-11-14 | 8.91M shares derived: average of 2 quarters · filed 2013-11-14 | 801.80K shares 10-Q · filed 2013-11-14 | 11.16M shares 10-Q · filed 2012-11-14 | 316.46K shares derived: average of 4 quarters · filed 2013-11-14 | |||
| 2012-06-30 | 17.02M shares 10-Q · filed 2013-08-13 | 17.02M shares 10-Q · filed 2013-08-13 | 11.16M shares 10-Q/A · filed 2012-08-29 | 154.68K shares derived: average of 3 quarters · filed 2013-08-13 | 2.90M shares derived: average of 4 quarters · filed 2013-08-13 | |||
| 2012-03-31 | 13.70M shares 10-Q · filed 2013-05-15 | -8.28M shares derived: average of 2 quarters · filed 2013-05-15 | -1.80M shares derived: average of 3 quarters · filed 2013-05-15 | |||||
| 2011-12-31 | -30.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -9.55M shares derived: average of 2 quarters · filed 2013-03-29 | 801.80K shares 10-K · filed 2013-03-29 | |||||
| 2011-09-30 | 11.16M shares derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | 11.16M shares 10-Q · filed 2012-11-14 | ||||||
| 2011-06-30 | 11.16M shares 10-Q/A · filed 2012-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |